These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37369246)

  • 1. Convergence of endobariatrics and endohepatology for evaluation and treatment of obesity and nonalcoholic fatty liver disease.
    Krishnan A; Shah-Khan SM; Hadi Y; Thakkar S; Singh S
    Endoscopy; 2023 Dec; 55(S 01):E841-E843. PubMed ID: 37369246
    [No Abstract]   [Full Text] [Related]  

  • 2. Convergence of endobariatrics and endohepatology for evaluation and treatment of obesity and nonalcoholic fatty liver disease.
    Krishnan A; Shah-Khan SM; Hadi Y; Thakkar S; Singh S
    Endoscopy; 2023 Nov; 55(11):1052-1054. PubMed ID: 37883962
    [No Abstract]   [Full Text] [Related]  

  • 3. The Future of Nonalcoholic Fatty Liver Disease Treatment.
    Mazhar K
    Med Clin North Am; 2019 Jan; 103(1):57-69. PubMed ID: 30466676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease (NAFLD) pathophysiology in obese children and adolescents: update.
    Assunção SNF; Sorte NCB; Alves CD; Mendes PSA; Alves CRB; Silva LR
    Nutr Hosp; 2017 Jun; 34(3):727-730. PubMed ID: 28627213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to consider a holistic approach to the treatment of non-alcoholic fatty liver disease in obese young people?
    Byrne CD; Targher G
    Gut; 2023 Jul; 72(7):1238-1239. PubMed ID: 35944926
    [No Abstract]   [Full Text] [Related]  

  • 6. The intersection of nonalcoholic fatty liver disease and obesity.
    Woo Baidal JA; Lavine JE
    Sci Transl Med; 2016 Jan; 8(323):323rv1. PubMed ID: 26819197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Weighty Issue of Treating Obesity in Patients With Nonalcoholic Fatty Liver Disease.
    Adams LA
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):505-507. PubMed ID: 34175461
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnosis and treatment strategy of pediatric nonalcoholic fatty liver disease].
    Zhou XL; Fu JF
    Zhonghua Er Ke Za Zhi; 2024 Jun; 62(6):590-592. PubMed ID: 38763887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond a liver-gut focus: the evolution of gastroenterology and hepatology in challenging the obesity and steatotic liver disease paradigm.
    Brennan PN; Zelber-Sagi S; Allen AM; Dillon JF; Lazarus JV
    Gut; 2024 Mar; 73(4):560-563. PubMed ID: 37898546
    [No Abstract]   [Full Text] [Related]  

  • 10. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.
    Polyzos SA; Kountouras J; Mantzoros CS
    Metabolism; 2019 Mar; 92():82-97. PubMed ID: 30502373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease: a systematic review.
    Rinella ME
    JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients.
    Muzurović E; Rizzo M; Mikhailidis DP
    J Diabetes Complications; 2022 Dec; 36(12):108359. PubMed ID: 36446208
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic Syndrome: Nonalcoholic Fatty Liver Disease.
    Williams T
    FP Essent; 2015 Aug; 435():24-9. PubMed ID: 26280342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
    Pallayova M; Taheri S
    Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
    Chun HS; Lee M
    Clin Mol Hepatol; 2023 Apr; 29(2):377-380. PubMed ID: 36907573
    [No Abstract]   [Full Text] [Related]  

  • 16. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
    Chalasani N; Younossi Z; Lavine JE; Charlton M; Cusi K; Rinella M; Harrison SA; Brunt EM; Sanyal AJ
    Hepatology; 2018 Jan; 67(1):328-357. PubMed ID: 28714183
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis and treatment strategies for fatty liver when obesity coexists with alcohol consumption].
    Sun FR; Wang BY
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):212-216. PubMed ID: 32306654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An interpretation of European guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease].
    Xin FZ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):403-5. PubMed ID: 27465941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.
    Diehl AM; Day C
    N Engl J Med; 2017 Nov; 377(21):2063-2072. PubMed ID: 29166236
    [No Abstract]   [Full Text] [Related]  

  • 20. [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016].
    Pár A; Pár G
    Orv Hetil; 2016 Jun; 157(25):987-94. PubMed ID: 27287838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.